tert-Butyl 4-(oxazol-5-yl)piperidine-1-carboxylate

Catalog No.: 
ACAUSM014
CAS No.: 
1260667-72-8
Molecular Formula: 
C13H20N2O3
Molecular Weight: 
252.31
tert-Butyl 4-(oxazol-5-yl)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$734.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-(oxazol-5-yl)piperidine-1-carboxylate
IUPAC Nametert-butyl 4-(oxazol-5-yl)piperidine-1-carboxylate
MDL No.MFCD18250328
Molecular FormulaC13H20N2O3
Molecular Weight252.31
SMILESO=C(N1CCC(C2=CN=CO2)CC1)OC(C)(C)C
InChI KeyOULPKAVLLHIBMT-UHFFFAOYSA-N
Synonym1-Piperidinecarboxylic acid, 4-(5-oxazolyl)-, 1,1-dimethylethyl ester;5-(1-Boc-4-piperidyl)oxazole
CAS No.1260667-72-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACAUSM014 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVEF156 route compound structure diagram
    ACQVEF156287192-97-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAUSM014 route product structure diagram
    ACAUSM0141260667-72-8
Inquiry

2. ACAUSM014 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAUSM014 route product structure diagram
    ACAUSM0141260667-72-8
Inquiry

3. ACAUSM014 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAUSM014 route product structure diagram
    ACAUSM0141260667-72-8
Inquiry

Comments (0)